Related Experiment Video
Updated: Apr 21, 2026

Application of Genetically Encoded Fluorescent Nitric Oxide (NO•) Probes, the geNOps, for Real-time Imaging of NO• Signals in Single Cells
Published on: March 16, 2017
Nitric oxide synthases: three pieces to the puzzle?
Mohammed Sabri Attia1, Eliott Lass, R Loch Macdonald
1Division of Neurosurgery, St. Michael's Hospital, 30 Bond Street, Toronto, ON, M5B 1W8, Canada.
Subarachnoid hemorrhage (SAH) is a severe stroke with limited treatments. This review explores how Nitric Oxide Synthases (NOSes) contribute to SAH complications, impacting patient outcomes.
Area of Science:
- Neuroscience
- Vascular Biology
- Pathophysiology
Background:
- Subarachnoid hemorrhage (SAH) is a critical neurological emergency with high mortality and morbidity.
- Effective interventions for SAH remain limited, highlighting the need to understand its pathogenesis.
- Secondary complications significantly contribute to poor outcomes following SAH.
Purpose of the Study:
- To review the role of Nitric Oxide Synthases (NOSes) in the pathogenesis of subarachnoid hemorrhage.
- To elucidate the contribution of NOS-mediated pathways to secondary brain injury after SAH.
Main Methods:
- Literature review of studies investigating Nitric Oxide Synthases (NOSes) and subarachnoid hemorrhage (SAH).
- Analysis of experimental and clinical data on NOS expression and activity post-SAH.
- Synthesis of current understanding regarding NOS isoforms and their impact on SAH pathophysiology.
Main Results:
- Nitric Oxide Synthases (NOSes) play a complex role in the secondary phase of SAH.
- Both beneficial and detrimental effects of NOS activity have been reported, depending on the specific isoform and context.
- Evidence suggests NOS-mediated pathways contribute to cerebral vasospasm, inflammation, and oxidative stress after SAH.
Conclusions:
- Nitric Oxide Synthases (NOSes) are key players in the complex pathophysiology of subarachnoid hemorrhage.
- Targeting specific NOS isoforms may offer novel therapeutic strategies to mitigate secondary brain injury and improve outcomes after SAH.
- Further research is warranted to fully delineate the therapeutic potential of modulating NOS activity in SAH management.
More Related Videos
Related Concept Videos
Nitric Oxide Signaling Pathway
Antihypertensive Drugs: Vasodilators
2° Amines to N-Nitrosamines: Reaction with NaNO2
Nitrosation of Enols
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Inorganic Nitrogen Assimilation

